What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Disease
Emily Y. Chew mostly deals with Macular degeneration, Internal medicine, Retinopathy, Surgery and Randomized controlled trial.
Her studies deal with areas such as Eye disease and Age related as well as Macular degeneration.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Lutein, Zeaxanthin, Endocrinology and Polyunsaturated fatty acid.
Her research investigates the connection between Retinopathy and topics such as Diabetic retinopathy that intersect with problems in Laser coagulation, Cytokine, Pathology and Angiogenesis.
Her Randomized controlled trial research is multidisciplinary, incorporating perspectives in Placebo and Clinical trial.
Her Case-control study research incorporates themes from SNP, Genetics, Genome-wide association study and Polymorphism.
Her most cited work include:
- A global reference for human genetic variation. (8799 citations)
- Complement Factor H Polymorphism in Age-Related Macular Degeneration (3740 citations)
- A reference panel of 64,976 haplotypes for genotype imputation (1512 citations)
What are the main themes of her work throughout her whole career to date?
Emily Y. Chew focuses on Ophthalmology, Macular degeneration, Internal medicine, Age related and Visual acuity.
Her Ophthalmology research is multidisciplinary, relying on both Diabetic retinopathy and Prospective cohort study.
The study incorporates disciplines such as Eye disease and Genetics in addition to Macular degeneration.
Her Internal medicine research integrates issues from Diabetes mellitus, Endocrinology, Retinopathy and Surgery.
Emily Y. Chew interconnects Clinical trial and Optical coherence tomography in the investigation of issues within Visual acuity.
In Retinal, Emily Y. Chew works on issues like Retina, which are connected to Pathology.
She most often published in these fields:
- Ophthalmology (41.13%)
- Macular degeneration (40.30%)
- Internal medicine (18.74%)
What were the highlights of her more recent work (between 2019-2021)?
- Macular degeneration (40.30%)
- Ophthalmology (41.13%)
- Age related (17.74%)
In recent papers she was focusing on the following fields of study:
Emily Y. Chew spends much of her time researching Macular degeneration, Ophthalmology, Age related, Eye disease and Age-Related Eye Disease Study.
Her studies in Macular degeneration integrate themes in fields like Internal medicine, Confidence interval and Artificial intelligence.
Her Internal medicine research incorporates elements of Diabetes mellitus and Oncology.
Ophthalmology is closely attributed to Prospective cohort study in her study.
Her Age related research includes themes of Physiology and MEDLINE.
Her biological study spans a wide range of topics, including Clinical trial, Deep learning, Fundus, Hazard ratio and Cohort.
Between 2019 and 2021, her most popular works were:
- Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group (111 citations)
- Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. (47 citations)
- Deep-learning-based prediction of late age-related macular degeneration progression (25 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Her primary scientific interests are in Macular degeneration, Eye disease, Ophthalmology, Retinal and Visual acuity.
Emily Y. Chew is interested in Drusen, which is a branch of Macular degeneration.
Her studies in Eye disease integrate themes in fields like Prospective cohort study, Clinical trial, Fundus and Confidence interval.
Her biological study spans a wide range of topics, including Vascularity and Atrophy.
As a part of the same scientific study, Emily Y. Chew usually deals with the Retinal, concentrating on Retina and frequently concerns with Paraganglioma, Pheochromocytoma, Pathology, Perfusion and Angiogenesis.
Her work in the fields of Visual acuity, such as Macular telangiectasia, intersects with other areas such as Nomenclature and Clinical Practice.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
